{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:10:44Z","timestamp":1793045444350,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jhepr.2025.101634","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:41:34Z","timestamp":1760827294000},"page":"101634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The multi-omic basis for hepatic encephalopathy recurrence: Analysis of the THEMATIC trial"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-3681","authenticated-orcid":false,"given":"Jasmohan S.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8592-1145","authenticated-orcid":false,"given":"Masoumeh","family":"Sikaroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Leslie","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-9737","authenticated-orcid":false,"given":"Hannah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Matherly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Mousel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-6748","authenticated-orcid":false,"given":"Brian C.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-3909","authenticated-orcid":false,"given":"Leroy R.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"McGinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-3188","authenticated-orcid":false,"given":"Alexander","family":"Khoruts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Gillevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101634_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101634_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101634_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.24517","article-title":"Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts","volume":"22","author":"Lucidi","year":"2016","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101634_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.14309\/ajg.0000000000003317","article-title":"Enhancement of cirrhosis mortality prediction by including hepatic encephalopathy to Meld3.0 in a National veteran cohort","volume":"120","author":"Silvey","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101634_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/hep4.1950","article-title":"Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient","volume":"6","author":"Bloom","year":"2022","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101634_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101634_bib7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101634_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: the THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101634_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.14309\/ajg.0000000000002953","article-title":"The liver cirrhosis network cohort study: cirrhosis definition, study population, and endpoints","volume":"120","author":"Tapper","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101634_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101634_bib11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ajg.2017.6","article-title":"Successful resolution of recurrent Clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study","volume":"112","author":"Staley","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101634_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nbt.3601","article-title":"Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies","volume":"34","author":"Gohl","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhepr.2025.101634_bib13","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhepr.2025.101634_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nmeth.1650","article-title":"Bayesian community-wide culture-independent microbial source tracking","volume":"8","author":"Knights","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhepr.2025.101634_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/cbdv.200900324","article-title":"Network-based modeling of the human gut microbiome","volume":"7","author":"Naqvi","year":"2010","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jhepr.2025.101634_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cgh.2022.03.046","article-title":"Admission serum metabolites and thyroxine predict advanced hepatic encephalopathy in a multicenter inpatient cirrhosis cohort","volume":"21","author":"Bajaj","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101634_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011814","article-title":"PathIntegrate: multivariate modelling approaches for pathway-based multi-omics data integration","volume":"20","author":"Wieder","year":"2024","journal-title":"Plos Comput Biol"},{"key":"10.1016\/j.jhepr.2025.101634_bib18","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","article-title":"DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays","volume":"35","author":"Singh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhepr.2025.101634_bib19","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1007\/s12035-015-9445-2","article-title":"Dopamine burden triggers neurodegeneration via production and release of TNF-alpha from astrocytes in minimal hepatic encephalopathy","volume":"53","author":"Ding","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jhepr.2025.101634_bib20","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jcem.84.7.5864","article-title":"Sources and physiological significance of plasma dopamine sulfate","volume":"84","author":"Goldstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101634_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41538-024-00253-2","article-title":"Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis","volume":"8","author":"Braga","year":"2024","journal-title":"NPJ Sci Food"},{"key":"10.1016\/j.jhepr.2025.101634_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11011-024-01473-x","article-title":"Hepatic encephalopathy as a result of ammonia-induced increase in GABAergic tone with secondary reduced brain energy metabolism","volume":"40","author":"Sorensen","year":"2024","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhepr.2025.101634_bib23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jhep.2021.08.004","article-title":"Microbiome therapeutics for hepatic encephalopathy","volume":"75","author":"Bloom","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101634_bib24","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/s41564-023-01493-w","article-title":"Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease","volume":"8","author":"Odenwald","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jhepr.2025.101634_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"issue":"24","key":"10.1016\/j.jhepr.2025.101634_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133410","article-title":"Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis","volume":"4","author":"Bajaj","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhepr.2025.101634_bib27","doi-asserted-by":"crossref","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2025.101634_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-alpha reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial","volume":"76","author":"Patel","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101634_bib29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101634_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00203-018-1506-2","article-title":"Smoking and the intestinal microbiome","volume":"200","author":"Savin","year":"2018","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.jhepr.2025.101634_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.livres.2024.12.002","article-title":"Cigarette smoking and alcohol-related liver disease","volume":"8","author":"Lin","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2025.101634_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1531131","article-title":"Synthetic vs. non-synthetic sweeteners: their differential effects on gut microbiome diversity and function","volume":"16","author":"Kidangathazhe","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhepr.2025.101634_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100072","article-title":"Aspartame, acesulfame K and sucralose- influence on the metabolism of Escherichia coli","volume":"8","author":"Shahriar","year":"2020","journal-title":"Metabol Open"},{"key":"10.1016\/j.jhepr.2025.101634_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjmed.2023.10.022","article-title":"The safe use of analgesics in patients with cirrhosis: a narrative review","volume":"137","author":"Ma","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.jhepr.2025.101634_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2050640620975224","article-title":"Deprescribing medications that may increase the risk of hepatic encephalopathy: a qualitative study of patients with cirrhosis and their doctors","volume":"9","author":"Williams","year":"2021","journal-title":"United Eur Gastroenterol J"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:41:56Z","timestamp":1778096516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589555925003167"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101634","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multi-omic basis for hepatic encephalopathy recurrence: Analysis of the THEMATIC trial","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101634"}}